Melatonin exerts a range of physiological effects. However, the functional significance of melatonin in spermatogenesis and the underlying mechanisms remain unclear. MicroRNAs (miRNAs) are essential in the initiation and progression of testicular development, including spermatogenesis. Thus far, limited information is known about the role of miRNAs in melatoninmediated spermatogenesis. In this study, the expression levels of testicular miRNA machinery genes, namely, Dgcr8 and Xpo5, were significantly increased by melatonin. The miRNA expression profile was identified in the testes of melatonin-treated mice. Ten miRNAs were significantly up-regulated, and 15 miRNAs were down-regulated. Melatonin (25 lM) enhanced cell growth and reduced apoptosis in GC-1 spg cells. Among the down-regulated miRNAs, miR-16 expression was influenced by melatonin in GC-1 spg cells. The miR-16 mimics in GC-1 spg cells significantly suppressed cell growth and promoted cell apoptosis. Conversely, transfection of the miR-16 inhibitor significantly increased cell growth and decreased cell apoptosis. The protein expression level of CCND1 (Cyclin D1) in GC-1 spg cells was decreased by the miR-16 mimics and increased by knockdown of miR-16. Moreover, bioinformatics and reporter activity analyses showed that Ccnd1 was a potential target of miR-16. These results suggested that miR-16 may function as a novel regulator of testicular functions during melatonin stimulation by targeting Ccnd1.
INTRODUCTION
Testicular development and spermatogenesis are mainly governed by a complex network of signaling processes involving phase-specific and cellular-specific gene expression profiles, which are mainly controlled at the transcriptional and posttranscriptional levels [1, 2] . Small noncoding RNAs regulate gene expression by influencing mRNA stability.
Meanwhile, microRNAs (miRNAs) serve as posttranscriptional regulators by binding to the 3 0 untranslated regions (UTRs) of mRNAs to enhance mRNA degradation [3] . Hundreds of miRNAs were identified through microarray analysis in the testis, and different expression profiles were detected between immature and mature testes [4, 5] . Next-generation sequencing of prepubertal testis in mice (Postnatal Days 7, 10, and 14) showed that the robust expression of miRNAs encoded on the X chromosome in the Postnatal Day 14 testis may activate meiotic sex chromosome [6] . Moreover, changes in miRNA expression may be associated with early male germ cell development [6] .
Inhibition of the canonical miRNA biogenesis pathway in testis will disrupt testicular development and spermatogenesis. DROSHA is an RNase III enzyme essential for processing of primary miRNAs into precursor miRNAs. Germ-cell-specific knock out of Drosha leads to male infertility in mice because of loss of spermatocytes and spermatids [7] . DICER is a cytoplasmic RNase III enzyme responsible for producing mature miRNAs. Mice with inactivated Dicer in germ cells are also infertile because of disrupted spermatogenesis [8] . Simultaneous inactivation of miR-34b/c and miR-449 clusters in mice leads to seminiferous epithelial disorganization and male infertility [9] . In vitro analysis results showed that miR-184 promotes the proliferation of a germ cell line by targeting the nuclear receptor corepressor 2 (Ncor2) [10] . These findings indicate that miRNAs are important for testicular development and spermatogenesis.
Melatonin is a neurohormone secreted by the pineal gland and is important for animal reproduction [11] [12] [13] [14] . Although some of the biological roles of melatonin in reproduction are mediated by specific receptors, melatonin involves many nonreceptor-mediated actions on peripheral reproductive organs [15] . In males, melatonin influences testicular development by regulating the secretion of neurohormones and testosterone [12] . Studies on the roles of melatonin in male reproduction have focused on animals with seasonal reproduction. Melatonin injections inhibited testicular growth when administered before lights out on a long day (14L:10D) in marsh rice rat (Oryzomys palustris) [16] . Progressive treatment of male white-footed mice with melatonin over 10 days significantly decreased testicular and seminal vesicle mass as well as reduced or completely suppressed sperm production [17] . However, melatonin treatment has been reported to improve testicular development and semen quality of rams and male Damascus goats during the nonbreeding season [18, 19] .
Although no direct evidence supports the regulatory role of melatonin in reproduction of nonseasonal animals, melatonin exhibits antioxidant activity and thus prevents testicular damage caused by toxic environments and testicular inflammation [20] . In vitro studies demonstrated that the use of melatonin significantly increased the percentage of motile, progressive, rapid sperm cells; increased mitochondrial activity; and decreased endogenous NO levels. The protective role of melatonin in sperm cells may be mediated by melatonin receptor 1 and extracellular signal-regulated kinases [21] .
In vivo experiments showed that melatonin can reduce apoptosis in the uterus of Wistar rats exposed to continuous light [22] . Meanwhile, exogenous melatonin treatment can improve mouse embryo implantation and litter size. The correlations between melatonin and the status of the reproductive system in humans have been investigated. Exogenous melatonin supplementation prevents oxidative stress-evoked DNA damage in human spermatozoa [14] .
MicroRNAs regulate melatonin-induced gene expression and cell growth in breast cancer cells [23] . Interestingly, melatonin synthesis in the pineal gland is associated with miRNAs. Massive parallel sequencing revealed that the abundance of most pineal gland-enriched miRNAs increases during development, whereas miR-483 levels markedly decrease. It was found that miR-483 mediates melatonin synthesis in the pineal gland by suppressing the expression of arylalkylamine N-acetyltransferase [24] . However, data are unavailable on whether melatonin can partially influence the testicular function by miRNA regulation. Therefore, this study aims to determine whether miRNA expression is altered in response to melatonin exposure and whether these changes are involved in melatonin-induced cell growth in mouse testis.
MATERIALS AND METHODS

Animals and Treatments
Adult wild-type BALB/c male mice (8 wk old) were purchased from the Medical Department of Jilin University (Changchun, China). The mice were acclimatized for 1 wk in the animal house at a controlled temperature of 238C and humidity of 60% 6 5% under a 12L:12D cycle. Water and food were provided ad libitum. All animal protocols were carried out with the guidance of the Animal Care Committee at Jilin University. The mice were divided into two groups. Group I (control, n ¼ 8) mice were treated with saline as vehicle. Group II (treated, n ¼ 8) mice were treated with 10 mg/kg of melatonin purchased from Sigma-Aldrich. Melatonin was first dissolved in 0.1% dimethyl sulfoxide and then adjusted to the final administered volume with saline. Saline and melatonin solutions were then intraperitoneally administered at 1800. After 48 h of treatment at 1800, the animals were anesthetized and euthanized, and the testes were rapidly collected for further analysis.
Cell Culture
The mouse-derived spermatogonia cell line (GC-1 spg) cells were then purchased from ATCC. The cells were cultured in Roswell Park Memorial Institute medium (RPMI-1640) supplemented with 10% fetal bovine serum and antibiotics (100 IU/ml penicillin and 100 lg/ml streptomycin). Cells were maintained in a humidified incubator with 5% CO 2 to ensure complete attachment of the cells to the culture dish. At confluence, the cells were subcultured with 0.05% trypsin for further experiments. Cells in both control and treated groups were serum starved for 12 h, followed by melatonin treatment for 24 h.
MicroRNA Expression Microarray Experiments
Total RNA was harvested from testes using TRIzol (Invitrogen, Life Technologies) and miRNeasy mini kit (Qiagen) in accordance with the manufacturer's instructions. After RNA quantity measurement using NanoDrop 1000, the samples (control groups, n ¼ 3; treated groups, n ¼ 3) were labeled by using the miRCURY Hy3 Power labeling kit (Exiqon) and hybridized on the miRCURY LNA Array (v.16.0). After stopping the labeling procedure, the Hy3TM-labeled samples were hybridized on the miRCURYTM LNA Array (Exiqon) in accordance with the array's manufacturer's instructions. A total of 25 ll mixture from Hy3TM-labeled samples plus 25 ll hybridization buffer were first denatured for 2 min at 958C, incubated on ice for 2 min, and then hybridized to the microarray for 16-20 h at 568C in a 12-Bay Hybridization System (Nimblegen Systems, Inc.). Following hybridization, slides were obtained and washed several times using a wash buffer kit (Exiqon) as follows. The slides were washed for 2 min at 568C using wash buffer A, 2 min at room temperature with wash buffer B, 2 min at room temperature in wash buffer C, and then briefly in water. Finally, the samples were finally dried by centrifugation for 5 min at 400 rpm. Following the washing steps, the slides were scanned with the Axon GenePix 4000B microarray scanner. The scanned images were then imported into GenePix Pro 6.0 software for grid alignment and data extraction.
Replicated miRNAs were averaged, and miRNAs with intensities 50 in all the samples were chosen for calculating the median normalization factor. Expressed miRNA data were then normalized using the median value and chosen for differentially expressed miRNA screening. Median normalization was then used for data correction of different chips to the same level by adjusting the median of the log2 ratio to 0. To identify significant differentially expressed miRNAs, we performed a volcano plot filtering between the two experimental groups. The threshold we used to screen the up-or downregulated miRNAs are fold change 1.5 and P value 0.05. Finally, hierarchical clustering was performed to distinguish the expression profiles of miRNAs among the samples.
5-Triphosphate-Biotin Nick-End Labeling Assay
The In Situ Cell Death Detection Kit (Roche) was used to detect apoptosis in the testis. In accordance with the instructions, the formalin-fixed testes sections were dewaxed, rehydrated, maintained in PBS, and then in proteinase K solution. Sections were then washed three times with PBS before incubation for 1 h in 5-triphosphate-biotin nick-end labeling (TUNEL) mix (Roche) at 378C. Sections were immersed in 13 TdT stop buffer and washed in PBS; covered sections with 1:20 dilution of ExtrAvidin peroxidase antibody (SigmaAldrich; titer for all antibodies used in this study is 100 lg/ml) for 30 min at 378C. After three washes in PBS, detection was performed with diaminobenzidine (DAKO). Sections were then counterstained with Mayer hematoxylin, dehydrated, and mounted with Pertex (Cellpath).
FIG. 1. MiRNAs expression in the testis of melatonin-treated mouse. A)
Five genes involved in the miRNA-processing pathway in the mouse testes were determined using qRT-PCR. The expression levels of Dgcr8 and Xpo5 in the testis were significantly increased after the mouse was exposed to melatonin for 48 h. B) According to the microarray results, the expression of three up-regulated miRNAs (miR-300-5p, miR-185-3p, and miR-706) and two down-regulated miRNAs (miR-34b-5p and miR-16-5p) were quantified by qRT-PCR. A star indicates significant difference (P , 0.05).
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Real-Time Quantitative PCR
Total RNA was extracted from testes using TRIzol reagent in accordance with the manufacturer's protocol (Invitrogen, Life Technologies). Quantitative real-time PCR (qRT-PCR) analyses for miRNAs identified by miRNA microarray and mRNAs of Dicer1, Ago2, Dgcr8, Drosha, Xpo5, and Hprt were performed by using PrimeScript RT Reagent Kit with gDNA Eraser (Takara-Bio). Reverse-transcription reactions were then performed as follows: 428C for 5 min, 428C (miRNA) or 378C (mRNA) for 30 min, and 858C for 2 min. PCR reactions were then performed using the following parameters: 958C for 2 min followed by 40 cycles of 958C for 15 sec and 598C for 30 sec. An U6 small nuclear RNA was used as an endogenous control for data normalization of miRNAs, and hprt was adopted as an internal control of mRNA expression. Relative expression was then calculated by the comparative threshold cycle (Ct) method. The sequences of primers used for reverse transcription and qRT-PCR are shown in Supplemental Table S1 (available online at wwwbiolreprod.org).
Western Blot Analysis
Total protein was isolated with lysis buffer supplemented with 1 mM phenylmethanesulfonyl fluoride (Beyotime Bio). Protein concentration was then measured by Bio-Rad protein assay kit (Bio-Rad Laboratories). Protein (20 lg) normalized from each sample was electrophoresed on 12% sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) gels. Membranes were then blocked with 25 mM Tris and 140 mM NaCl with 0.05% Tween-20 containing 5% nonfat milk and incubated with rabbit antimouse polyclonal antibodies specific to CCND1, BCL-2, BAX, and GAPDH (Beyotime Bio) at 48C overnight. After reaction with horseradish peroxidaseconjugated goat anti-rabbit secondary antibody for 1 h, the membranes were detected with BeyoECL Plus kit (Beyotime Bio) in accordance with the manufacturer's protocols.
Immunofluorescence Analysis
Cells were fixed with precooled absolute methanol for 10 min and treated with 0.1% Triton X-100 (Sigma Co.) for 5 min at room temperature. The cells were then blocked with normal goat serum (10%) in PBS at room temperature for 30 min and incubated with melatonin receptors 1 and 2 antibodies (1:300 dilution) (Boster Co.) at 48C for overnight. Following three washes with PBS, the slides were exposed to goat anti-rabbit IgG conjugated with fluorescein isothiocyanate (1:100 dilution) (Boster Co.) for 60 min at room temperature and then washed with PBS. The cell nucleus were stained with propidium iodide (PI) for 5 min. Negative controls were obtained by incubating slides with bovine serum albumin diluted with PBS instead of primary antibody. Slides covered with 90% glycerol were finally examined under a fluorescence microscope (Olympus Co.).
Cell Proliferation Assay
Cell proliferation was determined using the WST-1 assay (Beyotime Bio). Briefly, the cells were seeded at an approximate density of 1 3 10 4 cells per well in 96-well culture plates. At the indicated time points, 10 ll of the WST-1 solution was added to each well and then incubated for 2 h. The cell numbers were determined by triplicate measurements of absorbance in a 96-well format plate reader (ELX 800 universal microplate reader; BioTek, Inc.) at a wavelength of 450 nm.
Cell Cycle Analysis
Cell cycle distribution was then assessed by PI staining (Beyotime Bio). Adherent cells were then harvested with trypsin and washed with PBS. The detached cells were fixed in 70% ethanol at 48C for 12 h. After removal of the ethanol by centrifugation, the cells were washed with PBS and then stained with 50 lg/ml PI and 50 lg/ml RNase A at 378C for 30 min. Samples were then analyzed using a Cytomics FC500 flow cytometer (Beckman-Coulter) and at least 10 000 cells were analyzed per sample. Data were analyzed using the Windows Multiple Document Interface for Flow Cytometry, version 2.9, software.
Apoptosis Assay
Apoptosis was then assessed by an Annexin V-Fluorescein Isothiocyanate Apoptosis Detection kit (Boster) in accordance with the manufacturer's instructions. Cell pellets were resuspended in 100 ll buffer with 5 ll of annexin V and 1 ll of PI and incubated for 15 min at 258C in the dark. A total of 400 ll of buffer was added for a final volume of 500 ll. Cells were immediately analyzed with a Cytomics FC500 Flow Cytometer (Beckman-Coulter). Annexin V is a sensitive probe for quantifying apoptotic cells. Meanwhile, PI is a probe for discriminating between apoptotic and necrotic cells. A total of 10 000 cells per sample were acquired, and the percentage of cell death was analyzed using CellQuest software. The apoptotic cells were both early and late apoptotic cells.
Transient Transfection and Luciferase Activity Assay
Mouse GC-1 spg cells were transfected with either miRNA mimics/ inhibitors or plasmids with Lipofectamine 2000 (Invitrogen, Life Technologies) in accordance with the manufacturer's instructions. The miRNA mimic duplexes and inhibitors used in the study were chemically synthesized by RiboBio. After 12 h transfection with inhibitors, cells were treated with melatonin for another 24 h. For reporter assays, GC-1 spg cells were transiently cotransfected with reporter plasmids (wild-type 3 0 UTR or mutated type 3 0 UTR of Ccnd1, where GCUA was mutated as AATA) and miRNA mimics or mimic control in a 12-well plate. In all the experiments, the transfection efficiency of miR-16 mimics, miR-16 inhibitor, and reporter plasmids was over 90%. Cell extracts were prepared 24 h later, and the ratio of Renilla to firefly luciferase was measured with a Dual-Luciferase Reporter Assay System (Promega).
Statistical Analysis
The experiments of cell growth analysis, real-time PCR, cell cycle, and cell apoptosis were performed with three technical replicates. Six testes samples from six mice (control: n ¼ 3; treated, n ¼ 3) were then used for microarray analysis. The differences between the control and treated groups were determined using two-tailed Student t-test, and the differences between groups 
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were compared by one-way ANOVA, followed by Dunnet multiple range test or chi-squared test for multiple comparisons using SPSS software. The results are expressed as mean 6 standard deviation. A P value of , 0.05 was then considered statistically significant.
RESULTS
MicroRNA biosynthesis involves several miRNA machinery genes in multiple steps. The effect of melatonin on the expression of five genes involved in the miRNA-processing pathway in mouse testis was determined by qRT-PCR. The expression levels of Dgcr8 and Xpo5 in the testis were significantly increased after mouse exposure to melatonin for 48 h, indicating that melatonin might regulate miRNA expression by influencing the expression of miRNA machinery genes (Fig. 1A) .
In the present study, changes in the miRNA expression in the testes of mice treated or not treated with melatonin were identified using miRNA microarray assays. Microarray results revealed 25 significant differentially regulated miRNAs in the testis, of which 10 were up-regulated and 15 were downregulated during melatonin treatment (Table 1 ). All miRNAs identified are provided in Supplemental Table S1 . In accordance with the microarray results, miR-300-5p, miR-185-3p, miR-706, miR-34b-5p, and miR-16-5p were chosen to further confirm their expression by qRT-PCR (Fig. 1B) .
FIG. 2. TUNEL staining in testis paraffin sections after 48 h melatonin treatment and the effect of melatonin on the cell growth of mouse-derived spermatogonia cell line GC-1 spg cells. No obvious apoptotic cells (dyed brown) were observed in testis between control-and melatonin-treated mice (A).
After 24 h treatment, cell growth was analyzed. Melatonin significantly promoted cell growth (B). Bar ¼ 100 lm. A star indicates significant differences (P , 0.05).
LI ET AL.
The effect of melatonin on cell apoptosis in testis was evaluated with TUNEL after mouse treatment with melatonin. TUNEL activity is shown in Figure 2A . No significant increase in the apoptotic index of cells in sections was observed between the control and melatonin-treated groups. The effect of melatonin on the growth of GC-1 spg cells was determined by cell growth assays after treatment with melatonin at different concentrations for 24 h. The results showed that the growth of GC-1 spg cells was markedly regulated by melatonin. Melatonin at certain concentrations (,25 lM) could promote cell growth (Fig. 2B) . Interestingly, luzindole, a selective melatonin receptor 1 and 2 antagonist, blocked the stimulatory effect of melatonin on cell growth, indicating that the role of melatonin in GC-1 spg cells was mediated by melatonin receptors (Fig. 3D) . Furthermore, to corroborate the presence of melatonin receptors 1 and 2 in GC-1 spg cells, the cells were stained with immunofluorescence, and both melatonin receptor 1 and 2 proteins were identified in the GC-1 spg cells (Fig. 3,  A-C) .
Cell cycle phase distribution was examined 24 h after melatonin treatment. Melatonin (25 lM) decreased the percentage of cells in the G1 phase and increased the percentage of cells in the S phase compared with the control (Fig. 4A) . The potential effect of melatonin on apoptosis in GC-1 spg cells was evaluated with annexin V and PI double staining. When the double-stained cells were analyzed by flow cytometry, the results revealed that 25 lM melatonin did not influence the percentage of apoptotic cells between the treated and the control groups (Fig. 4B) . To further examine whether the melatonin-induced growth and apoptosis in the GC-1 spg cells were associated with the modulation of regulatory proteins in apoptosis and the cell cycle, the expression levels of CCND1, BAX, and BCL-2 were ascertained. The expression of CCND1 was significantly altered in response to melatonin treatment (Fig. 4C) . BAX level was remarkably decreased in response to 25 lM melatonin treatment, whereas BCL-2 level was increased (Fig. 4C) . However, the mRNA levels of Ccnd1, 
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Bax, and Bcl-2 was not changed in the testis after mouse treatment with 10 mg/kg melatonin for 48 h (Fig. 4D) .
Previous studies reported that miR-16 can modulate the cell cycle, inhibit cell proliferation, and promote cell apoptosis [10] . Therefore, to determine the effects of melatonin on miR-16 expression, GC-1 spg cells were treated with 25 lM melatonin for 24 h. The expression level of miR-16 significantly decreased after treatment with 25 lM melatonin (Fig. 5A) .
To determine the potential role of miR-16 in mediating melatonin-induced growth and apoptosis, the effects of miR-16 on the growth and apoptosis in GC-1 spg cells were tested. The WST-1 assay showed that miR-16 mimics caused a significant inhibition of cell growth (Fig. 5B) , significantly decreasing the percentage of cells in the S phase and increasing the percentage of cells in the G1 phase (Fig. 5C ). On the other hand, transfection of miR-16 mimics induced a greater proportion of apoptotic cells than the control (Fig. 5D ). However, a miR-16 inhibitor increased the cell growth and percentage in the S phase (Fig. 6, A and B) . The miR-16 inhibitor did not significantly influence the number of apoptotic cells (Fig. 6C) . Meanwhile, the miR-16 inhibitor decreased the expression of BAX and increased the expression of BCL-2 (Fig. 6D) .
The potential targets involved in cell cycle and apoptosis were identified using miR Base Targets, TargetScan, and PicTar program. Among the candidate miR-16 targets, Ccnd1, which is responsible for cell growth, was the focus of this study. The 3 0 UTR of Ccnd1 mRNA of mouse, human, pig, rat, and cattle were aligned with the sequence of mature miR-16. Putative target sites for miR-16 were then identified in this region across different species (Fig. 7A) . To determine whether Ccnd1 gene was a true target of miR-16, GC-1 spg cells were transfected with miR-16 mimics/ control or miR-16 inhibitor/control. Immunoblot analysis revealed that CCND1 protein expression was significantly lower in miR-16-transfected GC-1 spg cells compared with the control (Fig. 7B) , whereas the knockdown of miR-16 with inhibitors was able to increase CCND1 protein expression in GC-1 spg cells (Fig. 7B) . To further confirm that Ccnd1 was negatively regulated by miR-16, the Renilla luciferase reporter plasmids containing the entire wild-type 3 0 UTR of Ccnd1 as well as mutant forms were constructed and transfected into GC-1 spg cells along with miR-16 mimics/control. The results showed that miR-16 mimics decreased the activity of the luciferase reporter but did not change the activity of the seeding-site-mutated luciferase reporter (Fig. 7C) .
DISCUSSION
Spermatogenesis is a complex and highly regulated process that supports the production of millions of sperm, which requires the coordination of both somatic and germ cells through the phases of proliferation, meiosis, and differentiation within the seminiferous tubules. Hormones released by the hypothalamic-pituitary-testis axis are the main factors in regulating a successful process of spermatogenesis [25] . . When GC-1 spg cells were treated with 25 lM melatonin, no difference in percentage of apoptotic cells between the treated and control groups was noted (B). Expression of CCND1 was significantly increased in response to 25 lM melatonin treatment. BAX level was then remarkably decreased in response to 25 lM melatonin treatment, whereas BCL-2 levels were increased (C). However, the mRNA levels of Ccnd1, Bax, and Bcl-2 were not altered in the testis when the mouse was treated with 10 mg/kg melatonin for 48 h (D). Columns without a common superscript indicate significant differences (P , 0.05).
Recently, growing evidence has shown that miRNAs are involved in spermatogenesis and are responsible for mitotic, meiotic, and postmeiotic stages of spermatogenesis by influencing the expression of target genes [26] . Some unique miRNAs have been identified from somatic and germ cells in the testis [27] . Exogenous melatonin has been demonstrated to possess a number of beneficial effects in the testis [12] . Melatonin receptors have been identified in the testis, indicating that melatonin can affect the testes directly by binding to specific receptors [28] . Treatment of mature mice with 10 mg/kg melatonin daily for 14 days adversely affects seminiferous tubules in the testes. [29] . However, melatonin has been proven as a powerful antioxidant that protects the testes from environmental damage and inflammation by removing reactive oxygen species, which can cause DNA damage and impairment of protein function [30] .
Emerging research is currently being focused on identifying miRNAs that may play a crucial role in testicular development and spermatogenesis. Thus, a study of the possible effects of melatonin on the expression profile of miRNAs in testis is potentially important for understanding the mechanism of melatonin in the testis. However, the expression patterns of miRNAs in the testis of melatonin-treated mouse have not been studied. Thus, a direct link between miRNAs and melatonin pathways during testicular development is explored here for the first time.
The miRNA machinery genes include Drosha, Dgcr8, Dicer1, Xpo5, and Ago2, which synthesize proteins to precisely regulate miRNA processing [31] . Different expression profiles of these genes were associated with miRNA expression. In this study, we detected the mRNA expression patterns of miRNA machinery genes by using qRT-PCR. The results showed that melatonin could affect the expression of Xpo5 and Dgcr8. Exportin 5 (XPO5)-mediated nuclear export of pre-miRNAs has been shown as a rate-limiting step of miRNA biosynthesis and therefore might be critical for the quantitative control of global miRNA levels [32] . During miRNA biosynthesis, DGCR 8 interacts with Drosha, being important components of the primary RNA-processing complex. Germ cell-specific targets of Dgcr8 led to complete male infertility because of alterations in meiotic progression and increased spermatocyte apoptosis [33] . These indirect finds emphasize the essential role of miRNAs in the progression of spermatogenesis. The different expression of Xpo5 and Dgcr8 in the testis induced by melatonin potentially indicates that miRNA biosynthesis in the testis might be regulated by melatonin. In this study, using microarrays, we investigated the effect of melatonin on miRNA expression patterns in the testis. We identified the differential expression of 25 miRNAs in the testis of melatonin-treated mice compared with the control. The miRNAs showed differential expression: 10 were up-regulated and 15 were down-regulated. Regulation of miRNAs expression by melatonin has been explored in MCF-7 human breast cancer cells, and 22 miRNAs were differentially expressed in melatonintreated MCF-7 cells [14] . In PC-3 prostate cancer cells, melatonin can inhibit cell growth by up-regulating miRNA- LI ET AL. biological roles of melatonin may be partially elicited by the regulation of miRNA expression levels.
In the present study, mouse-derived spermatogonia cell line GC-1 spg cells were used as a model to investigate the role of melatonin in spermatogenesis. Melatonin showed obvious regulatory roles in cell growth, cell cycle, and apoptosis. Melatonin increased the growth of GC-1 spg cells. These results indicate that at a suitable concentration, melatonin can play a beneficial role in spermatogenesis. The regulatory role of melatonin in gonadal cells has been explored. In males, melatonin could up-regulate the expression of spermatogenesis-related genes in bovine Sertoli cells [35] . Melatonin supplementation might be an effective therapy for diabetic male rats with subfertility/infertility through regulating the metabolism of Sertoli cells [36] . In females, melatonin has been shown to be beneficial to oocyte maturation in vitro [37] [38] [39] . Meanwhile, melatonin protects luteinizing follicular granulosa cells from reactive oxygen species and contributes to luteinization and progesterone production during ovulation [40] .
The differentially expressed miRNAs identified in the present study have been shown to be associated with multiple biological events. For example, miR-185 can repress the ATR pathway and enhance radiation-induced apoptosis and proliferation inhibition [41] . Inactivation of miR-34b/c leads to sexual dimorphism, partial perinatal lethality, growth retardation, and infertility in male mice [9] ; miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer [42] ; and miR-16, identified as a miRNA cluster, is located in chromosome 13 (13q14) in human and chromosome 14 (14qC3) in mice [43, 44] and belongs to the miR-16 family, including miR-16, miR-15, and miR-195 [43] . MicroRNA microarray has shown expression of miR-16 in testicular tissues of immature rhesus monkey, mature rhesus monkey, and mature human [45] . Hsamir-16 has been reported as a housekeeping miRNA expressed in all of the tissues tested with evenly abundant levels and may be important for the regulation of basic cellular functions in testicular tissues [46] . Although no direct evidence regarding the role of miR-16 is present in spermatogenesis, miR-15a, a member of the miR-16 family, has been shown to be involved in spermatogenesis by targeting Ccnt2 [47] .
A previous study [48] found that miR-16 has been found to be a tumor-suppressor gene and down-regulated in many types of cancer, and its increasing its level will enhance apoptosis and retard the cell cycle of cancer cells by targeting Bcl-2 and the cyclin gene family [49, 50] . We then investigated the effect of melatonin on the expression of miR-16 in GC-1 spg cells. The expression of miR-16 was decreased by melatonin. Transfection with miR-16 mimics in GC-1 spg cells significantly suppressed cell growth and promoted cell apoptosis. However, miR-16 inhibitor significantly increased cell growth and inhibited cell apoptosis. These results indicate that miR-16 might be involved in melatonin-induced cell growth. In GC-1 spg cells, Ccnd1 level was regulated by melatonin. We asked whether Ccnd1 mediated the effect of miR-16 in GC-1 spg cells. The miR-16 mimics decreased but miR-16 inhibitor increased CCND1 protein expression level. In addition, miRNA-16 mimics reduced Ccnd1 3 0 UTR reported activity; however, no inhibition of reporter activity was observed when Ccnd1 3 0 UTR sites matching the seeding sequence of miR-16 were mutated. These results confirm that Ccnd1 is a miR-16 target. CCND1, a critical member of the cyclin proteins, is expressed during G1 and drives the G1/S phase transition [51] .
In summary, we have identified the miRNA expression signature of melatonin-exposed mouse testis. Functional characterization of one of 25 miRNAs reveals that miR-16 is regulated by melatonin, mediates the melatonin-induced cell growth, and functions through a target Ccnd1 in GC-1 spg cells. For the first time, these findings demonstrate that melatonin exerts its biological functions in testicular functions by modulating miRNA expression. Given the lack of a spermatogenic differentiation model in vitro, we cannot observe the effects of melatonin and miR-16 on germ cell differentiation directly. Further study using miR-16 genetically inactivated mice might help clarify their effects on this process.
